The Central Department of Pharmaceutical Affairs of the Ministry of Health and Population (MOHP) has recalled around 14 high blood pressure medications that contain the heart drug “Valsartan”, due to an impurity discovered that could lead to cancer, according to the U.S. Food and Drug Administration (FDA).
“This recall is due to an impurity, N-nitrosodimethylamine (NDMA), which was found in the recalled products. However, not all products containing Valsartan are being recalled,” FDA says. ” Hence the drug manufactures in Egypt were addressed by the MOHP to bring to a halt all of these medicines from the Egyptian markets, and what has been distributed already.
It’s no secret that defective products are incredibly dangerous, but ultimately, the injuries caused by defective medical devices and drugs can be particularly tragic. If you’re an Atlanta, Georgia resident and you need an experienced defective drug attorney to get your defective drug lawsuits off the ground, you could consider contacting a specialist firm like Watkins, Lourie, Roll & Chance, PC.
While many people gained information on the dangerous substances that can cause cancer over the past years, not many knew that this NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. However, according to the FDA, the presence of this substance was unexpected and due to changes in the way active substance was manufactured.